Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19.
Paulo Ricardo Saquete Martins FilhoJosé Augusto Soares Barreto-FilhoVictor Santana SantosPublished in: Arquivos brasileiros de cardiologia (2020)
The confirmation that underlying cardiovascular conditions, elevation of myocardial injury biomarkers during COVID-19 infection, and acute cardiovascular decompensation are predictors for mortality in SARS-CoV-2 infection must encourage new research to clarify potential mechanisms and test appropriate treatments. (Arq Bras Cardiol. 2020; 115(2):273-277).